Related Experiment Video
Updated: Mar 5, 2026

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
Arterial stiffness in HIV-infected youth and associations with HIV-related variables
Allison Ross Eckard1,2, Paolo Raggi2,3, Joshua H Ruff4
1a Medical University of South Carolina , Charleston , SC , USA.
Insights
Pulse wave velocity (PWV) did not differ between HIV-infected youth and controls. However, PWV correlated with arterial stiffness and alcohol use in HIV-infected youth, suggesting its potential for cardiovascular disease risk assessment.
Area of Science:
- Cardiology
- Pediatrics
- Infectious Diseases
Background:
- Children and young adults with HIV face increased cardiovascular disease (CVD) risk.
- Non-invasive methods like pulse wave velocity (PWV) for subclinical CVD detection in this population are understudied.
- Arterial stiffness, measured by PWV, is a key indicator of CVD risk.
Purpose of the Study:
- To evaluate PWV as a measure of arterial stiffness in HIV-infected youth.
- To assess the correlation between PWV and subclinical atherosclerosis (carotid intima-media thickness, IMT).
- To compare PWV in HIV-infected youth with healthy controls and identify associated variables.
Main Methods:
- Carotid-femoral PWV and carotid IMT were measured in 101 HIV-infected youth (8-25 years) on antiretroviral therapy and 86 healthy controls.
- Statistical analyses included group comparisons and multivariable regression.
- Variables assessed included age, body mass index, blood pressure, alcohol, and marijuana use.
Main Results:
- No significant difference in PWV was found between HIV-infected youth and healthy controls (5.7 m/s vs 5.7 m/s).
- In HIV-infected youth, PWV positively correlated with internal carotid artery IMT (R=0.31, P=0.02) and carotid bulb IMT (R=0.29, P=0.01).
- Current alcohol consumption and systolic blood pressure were independently associated with higher PWV in HIV-infected youth.
Conclusions:
- Arterial stiffness, measured by PWV, is not significantly different between HIV-infected youth and controls.
- PWV shows potential as a non-invasive tool to assess CVD risk in HIV-infected youth, particularly its association with carotid atherosclerosis.
- Further research is warranted to confirm the utility of PWV in managing CVD risk in this vulnerable population.
Abstract:
Children and young adults infected with HIV are at elevated risk for cardiovascular disease (CVD). However, scarce data exist on the utility of non-invasive methods to diagnose subclinical CVD, such as pulse wave velocity (PWV), a non-invasive measure of arterial stiffness. The objectives of this study were to assess the relationship of carotid-femoral PWV with subclinical atherosclerosis measured by carotid intima-media thickness (IMT), compare measurements to healthy controls, and evaluate variables associated with PWV in HIV-infected youth. One hundred and one 8-25 year-old subjects on stable antiretroviral therapy with low-level viremia or an undetectable HIV-1 RNA were enrolled, along with 86 healthy controls similar in age, sex and race. There was no significant difference in PWV between groups (median (Q1, Q3): 5.7 (5.2, 6.3) vs 5.7 (4.9, 6.5) m/s; P = 0.81). Among the HIV-infected subjects, PWV was positively correlated with both internal carotid artery (R = 0.31, P = 0.02) and carotid bulb IMT (R = 0.29, P = 0.01). In multivariable regression, only current alcohol consumption and systolic blood pressure were independently associated with PWV in the HIV-infected group (where current alcohol consumption and higher systolic blood pressure were associated with higher PWV); whereas, age, body mass index, and current marijuana use were associated with PWV in healthy controls. In this study of PWV in HIV-infected youth, measures of arterial stiffness were not different between subjects and controls. However, in HIV-infected youth, there was a significant association between PWV and carotid IMT, as well as between PWV and current alcohol consumption. Thus, PWV may have potential as a useful, non-invasive method to assess CVD risk in HIV-infected youth, but further investigation is needed.
Related Concept Videos
Sexually Transmitted Infections
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

